Michael J. Hayman

Hackensack Meridian Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

50h-index8.5kcitations211works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(42), Animal Virus Infections Studies(29), Liver physiology and pathology(22), Neuroblastoma Research and Treatments(20), Phagocytosis and Immune Regulation(20)

Publications210 total

<i>Candida glabrata</i> replicating within macrophages experiences amino acid deprivation, DNA damage, and chromosome instability
2025Open Access
RT-PCR analysis of EGFR extracellular domain mutations in the remaining COG NB RNA from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
RT-PCR analysis of EGFR extracellular domain mutations in the remaining CBRC NB tumors from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
RT-PCR analysis of EGFR extracellular domain mutations in the remaining COG NB RNA from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Erlotinib treatment effect on EGFRÎ"768+ and control GFP+ 3T3 clones from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Comparison of the biochemical response to erlotinib between the EGFRvIII+ and EGFRÎ"768+ BE2C clones from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Phosphoreceptor tyrosine kinase and phosphokinase array analyses of the EGFRvIII in the transiently transfected IMR32 cells from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Data from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Supplemental Figure Legends from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Erlotinib treatment effect on EGFRÎ"768+ and control GFP+ 3T3 clones from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Phosphoreceptor tyrosine kinase and phosphokinase array analyses of the EGFRvIII in the transiently transfected IMR32 cells from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
RT-PCR analysis of EGFR extracellular domain mutations in the remaining CBRC NB tumors from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Expression level of the EGFRÎ"768 and WT-EGFR in the stable 3T3 clones from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
STR profiles of the neuroblastoma cell lines from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
STR profiles of the neuroblastoma cell lines from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Expression level of the EGFRÎ"768 and WT-EGFR in the stable 3T3 clones from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Data from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Comparison of the biochemical response to erlotinib between the EGFRvIII+ and EGFRÎ"768+ BE2C clones from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Supplemental Figure Legends from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma
2023Open Access
Supplementary Figure 5A and 5B from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Hartmut Beug(7), Thomas Graf(6), Peter K. Vogt(5), Irene Ischenko(5), Gary Ramsay(5), Michaël J. Crumpton(4), Ingrid E. Scheffer(4), Yehenew M. Agazie(3), Klaus Bister(3), Samuel F. Berkovic(3), Nobuhide Ueki(3), Björn Vennström(2), John Pace(2), Jorge E. Galán(2), Oleksi Petrenko(2), Michael Fahey(2), Paula J. Enrietto(2), Richard Dahl(2), Gary M. Leong(2), Nanthakumar Subramaniam(2)